The current work demonstrates that ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, has potent neuroprotective and anti-inflammatory effects in preclinical models, demonstrating benefit across several key mechanisms of ALS-related pathogenesis. Here, HGF is linked to amyotrophic lateral sclerosis.